ADAM PADDOCK: Open Payments
NPI 1992131973 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 37 payments from 13 companies in 2025. Trend: 2023 $981 · 2024 $1,181 · 2025 $893
Food & beverage: $713Education: $180
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $177 |
| Janssen Biotech, Inc. | 4 | $141 |
| GENZYME CORPORATION | 4 | $126 |
| PFIZER INC. | 4 | $82 |
| Galderma Laboratories, L.P. | 4 | $81 |
| UCB, Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Organon LLC | 3 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| ABBVIE INC. | 2 | $30 |
Products named: TREMFYA, DUPIXENT, CIBINQO, Bimzelx, ILUMYA, VTAMA, NEMLUVIO, SKYRIZI.
Industry payments across NY — which companies pay providers there.
